Preparing for future products of biotechnology / Committee on Future Biotechnology Products and Opportunities to Enhance Capabilities of the Biotechnology Regulatory System, Board on Life Sciences, Board on Agriculture and Natural Resources, Board on Chemical Sciences and Technology.

Author
National Academies of Sciences, Engineering, and Medicine (U.S.). Committee on Future Biotechnology Products and Opportunities to Enhance Capabilities of the Biotechnology Regulatory System [Browse]
Format
Book
Language
English
Published/​Created
  • Washington, DC : National Academies Press, 2017.
  • ©2017
Description
xviii, 212 pages : charts ; 26 cm

Availability

Available Online

Copies in the Library

Location Call Number Status Location Service Notes
ReCAP - Remote StorageTP248.185 .N38 2014g Browse related items Request

    Details

    Subject(s)
    Summary note
    "Between 1973 and 2016, the ways to manipulate DNA to endow new characteristics in an organism (that is, biotechnology) have advanced, enabling the development of products that were not previously possible. What will the likely future products of biotechnology be over the next 5-10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology? Preparing for Future Products of Biotechnology analyzes the future landscape of biotechnology products and seeks to inform forthcoming policy making. This report identifies potential new risks and frameworks for risk assessment and areas in which the risks or lack of risks relating to the products of biotechnology are well understood"--Publisher's description.
    Bibliographic references
    Includes bibliographical references.
    Contents
    • Introduction and context
    • Emerging trends and products of biotechnology
    • The current biotechnology regulatory system
    • Understanding risks related to future biotechnology products
    • Opportunities to enhance the capabilities of the biotechnology regulatory system
    • Conclusions and recommendations
    • Glossary
    • Appendix A: Biographical sketches of committee members
    • Appendix B: Agendas of information-gathering sessions
    • Appendix C: Requests for information
    • Appendix D: Congressionally defined product categories that the U.S. Food and Drug Administration regulates.
    ISBN
    • 0309452058
    • 9780309452052
    OCLC
    994315138
    RCP
    C - S
    Statement on language in description
    Princeton University Library aims to describe library materials in a manner that is respectful to the individuals and communities who create, use, and are represented in the collections we manage. Read more...